Nives Selak Bienz

790 citations
10 papers · 536 indexed · 1 hit paper · h-index 7
Topics
Hemophilia Treatment and Research (8 papers)Blood Coagulation and Thrombosis Mechanisms (4 papers)Platelet Disorders and Treatments (3 papers)

In The Last Decade

Nives Selak Bienz

10 papers receiving 527 citations

Hit Papers

Efficacy, safety, and pharmacokinetics of emicizumab prop...2019202620212023201950100150200250

Peers

Nives Selak Bienz
Comparison fields: 5 of 32
  • Hematology 516
  • Genetics 157
  • Molecular Biology 35
  • Surgery 30
  • Oncology 23
Replace Claude Négrier with:
Claude Négrier France
Sammy Chebon Switzerland
L. Rusen United States
M. Oh United States
Marianne Uguen Switzerland
F. Abdul Karim Denmark
G. Auerswald Germany
Sofia H. Giacomelli Italy
Daniella Kerbauy United States
Amir T. Fathi United States
Nives Selak Bienz relative to Claude Négrier France Claude Négrier's profile →
Citations per field
00.5×1.5×
Claude Négrier · 1×
Citations per year

Countries citing papers authored by Nives Selak Bienz

Since Specialization
Citations

This map shows the geographic impact of Nives Selak Bienz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nives Selak Bienz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nives Selak Bienz more than expected).

Fields of papers citing papers by Nives Selak Bienz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nives Selak Bienz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nives Selak Bienz. The network helps show where Nives Selak Bienz may publish in the future.

Co-authorship network of co-authors of Nives Selak Bienz

This figure shows the co-authorship network connecting the top 25 collaborators of Nives Selak Bienz. A scholar is included among the top collaborators of Nives Selak Bienz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nives Selak Bienz. Nives Selak Bienz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 30
3 3
4 170
5 4
6 12
7 8
8
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 studybreakdown →
273
9 28
10 2

About Nives Selak Bienz

Nives Selak Bienz is a scholar working on Hematology, Genetics and Cancer Research, having authored 10 papers that have together received 536 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (516 citations), Genetics (157 citations) and Oncology (23 citations). Nives Selak Bienz has collaborated with scholars based in Switzerland, United States and Japan. Frequent co-authors include Michaela Lehle, Sammy Chebon, Midori Shima, Víctor Jiménez‐Yuste, Gallia G. Levy, Steven W. Pipe, Christophe Schmitt, Maria Podolak‐Dawidziak, Katsuyuki Fukutake and Agnès Portron. Their work appears in journals such as Journal of Clinical Oncology, Blood and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026